Jean-Luc Dompé will be out for HSV for the time being. As a replacement, an actor who played hardly any role in the last ...

In his absence, winter signing Alexander Røssing-Lelesiit got a chance on the left wing. The 18-year-old once again showed ...

MILAN--(BUSINESS WIRE)--Dompé, one of Italy’s leading biopharmaceutical companies, announced today that it has entered into a definitive agreement to acquire 100% of Anabasis Srl, a privately ...

Dompé is a privately owned biopharmaceutical company with 130 years of history and expertise in life sciences. Headquartered in Milan, the company also has operations in Boston, San Francisco ...

Dompé, a leading biopharmaceutical company with operations in Italy and the US, appointed Shannon K. Sullivan as Chief Commercial Officer (CCO).

Dompé pha.r.ma s.p.a. and Axxam s.r.l. announced a research collaboration for the discovery and development of novel drugs based on GPCR targets. "The partnership between Dompé pha.r.ma and Axxam ...

As a condition for the exclusive negotiation rights that end at the end of September, Dompé entered into a securities sale agreement with Dyax to purchase 2,008,032 million shares of Dyax common ...

Jennifer Cross of Dompé on 'sacrificing yourself' and putting your team firstEditor’s note: This is an automatically generated transcript, which has been slightly edited for clarity. Please ...

The Dompé Foundation, has announced it doubled to $1 million its support to MA and Ph.D. candidates from US universities for 2023. This funding opportunity, which honors the legacy of the only ...

Article ‘Count’ and ‘Share’ for Dompé Corporate based on listed parameters only. According to the parameters selected above, there are no articles from Dompé Corporate from 1 December ...

Dompé is a private, rapidly scaling international biopharmaceutical company founded in Milan, Italy, with a 130-year legacy of medical innovation. The R&D department of the company is anchored by ...